Pediatric Access To Unapproved Drugs Is Next Topic For Oncology Subcmte
Pediatric use of unapproved cancer drugs will be the next topic on the table for FDA's Pediatric Subcommittee of the Oncologic Drugs Advisory Committee
Pediatric use of unapproved cancer drugs will be the next topic on the table for FDA's Pediatric Subcommittee of the Oncologic Drugs Advisory Committee